Monitoring genetic diversity of influenza A(H1N1)pdm09 virus circulating during the post-pandemic period in Turkey

Japanese Journal of Infectious Diseases

Volumn 66, Issue 4, 2013, Pages 299-305

  Guldemir, Dilek ^a   Kalaycioglu, Atila T ^a   Basak Altas, A ^a   Korukluoglu, Gulay ^a   Durmaz, Riza ^a,b  

^a Public Health Institution of Turkey   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; OSELTAMIVIR; VIRUS RNA;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BIOLOGICAL MONITORING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GLYCOSYLATION; HA GENE; HUMAN; INFANT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MALE; MUTATIONAL ANALYSIS; NA GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC; PRESCHOOL CHILD; PROTEIN DOMAIN; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEQUENCE HOMOLOGY; TURKEY (REPUBLIC); VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN;

EID: 84880676841     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.299     Document Type: Article

References (40)

1. Childs, R.A., Palma, A.S., Wharton, S., et al. (2003): Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol., 27, 797-799.
2. World Health Organization (2010): H1N1 now in the post-pandemic period. Online at http://www.who.int/csr/disease/swineflu/en/
3. World Health Organization (2010): H1N1 in post-pandemic period. Director-General's opening statement at virtual press conference-10 August 2010. Online at http://www.who.int/mediacentre/news/statements/2010/h1n1_vpc_20100810/en/index.html
4. World Health Organization (2010): WHO recommendations for the post-pandemic period. Online at http://www.who.int/csr/disease/swineflu/notes/briefing_20100810/en/index.html
5. Ciblak, M.A., Albayrak, N., Odabas, Y., et al. (2009): Cases of influenza A(H1N1)v reported in Turkey, May-July 2009. Euro Surveill., 14(33):19313.
6. Ertek, M., Durmaz, R., Guldemir, D., et al. (2010): Epidemiological, demographic, and molecular characteristics of laboratory-confirmed pandemic influenza A (H1N1) virus infection in Turkey, May 15-November 30, 2009. Jpn. J. Infect. Dis., 63, 239-245.
7. Tamura, K., Dudley, J., Nei, M., et al. (2007): MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol., 24, 1596-1599.
8. Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994): CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucl. Acids Res., 22, 4673-4680.
9. Hall, T.A. (1999): BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser., 41, 95-98.
10. European Centre for Disease Prevention and Control (2011): Influenza virus characterization surveillance report. Summary for Europe. Community Network of Reference Laboratories (CNRL) for Human Influenza in Europe; May-June 2011. Online at http://www.ecdc.europa.eu/en/publications/Publications/1106_Influenza_virus_characterisation.pdf
11. World Health Organization (2009): Pandemic (H1N1) 2009-update 77. Online at www.who.int/csr/don/2009_12_04/en/index.html
12. Cao, B., Li, Z.-W., Mao, Y., et al. (2009): Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N. Engl. J. Med., 361, 2507-2517.
13. World Health Organization (2011): Summary review of the 2010-2011 northern hemisphere winter influenza season. Online at http://www.who.int/influenza/surveillance_monitoring/2010_2011_GIP_surveillance_seasonal_review/en/
14. World Health Organization (2010): WHO-recommended viruses for influenza vaccines for use in the 2010-2011 Northern Hemisphere influenza season. 19 Feb 2010. Online at http://ecdc.europa.eu/en/activities/sciadvice/Lists/ECDCz20Reviews/ECDC_DispForm.aspx?List=512ff74f-77d4-4ad8-b6d6-bf0f23083f30&ID=732&MasterPage=1
15. Wiley, D.C. and Skehel, J.J. (1987): The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann. Rev. Biochem., 56, 365-394.
16. Matrosovich, M., Tuzikov, A., Bovin, N., et al. (2000): Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol., 74, 8502-8512.
17. World Health Organization (2009): Pandemic (H1N1) 2009-update 78. Online at http://www.who.int/csr/disease/swineflu/laboratory11_12_2009/en/index.html
18. Ledesma, J., Pozo, F., Reina, G., et al. (2012): Spanish Influenza Surveillance System (SISS). Genetic diversity of influenza A(H1N1)2009 virus circulating during the season 2010-2011 in Spain. J. Clin. Virol., 53, 16-21.
19. European Centre for Disease Prevention and Control (2011): Influenza virus characterization surveillance report. Summary for Europe. Community Network of Reference Laboratories (CNRL) for Human Influenza in Europe; July 2011. Online at http://www.ecdc.europa.eu/en/publications/Publications/1108_SUR_Influenza_virus_characterisation_July.pdf
20. European Centre for Disease Prevention and Control (2011): Influenza virus characterization surveillance report. Summary for Europe. Community Network of Reference Laboratories (CNRL) for Human Influenza in Europe; March 2011. Online at http://www.ecdc.europa.eu/en/publications/Publications/1304_Influenza_virus_characterisation_2011_April.pdf
21. European Centre for Disease Prevention and Control (2010): Influenza virus characterization surveillance report. Summary for Europe. Community Network of Reference Laboratories (CNRL) for Human Influenza in Europe; December 2010. Online at http://www.ecdc.europa.eu/en/publications/Publications/1012_Influenza_virus_characterisation_2010_December.pdf
22. Caton, A.-J., Brownlee, G.-G., Yewdell, J.-W., et al. (1982): The Antigenic structure of influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell, 31, 417-427.
23. Deem, M.-W. and Pan, K. (2009): The epitope regions of H1-sub-type influenza A, with application to vaccine efficacy. Protein Eng. Des. Sel., 22, 543-546.
24. Barr, I.-G., Cui, L., Komadina, N., et al. (2010): A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill., 15(42): 19692.
25. Mak, G.-C., Leung, C.-K., Cheng, K.-C., et al. (2011): Evolution of haemagglutinin gene of the influenza (AH1N1)2009 virus isolated In Hong Kong, 2009-2011. Euro Surveill., 16(9): 19807.
26. Ellis, J., Galiano, M., Pebody, R., et al. (2011): Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill., 16(1): 19760.
27. World Health Organization (2011): EuroFlu Weekly Electronic Bulletin, Week 4: 24.01.11-30.01.11, 04 February 2011. Number 387. Online at http://www.euroflu.org/bulletinspdf/eiss2011 4 bulletin.pdf
28. European Centre for Disease Prevention and Control (2012): Influenza virus characterization surveillance report. Summary for Europe. Community Network of Reference Laboratories (CNRL) for Human Influenza in Europe; November 2012. Online at http://www.ecdc.europa.eu/en/publications/Publications/influenza-virus-characterisation-november-2012l.pdf
29. Kilander, A., Rykkvin, R., Dudman, S.-G., et al. (2010): Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome. Norway 2009-2010. Euro Surveill., 15(9): 19498.
30. World Health Organization (2010): Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly. Epidemiol. Rec., 85, 21-28.
31. Balraj, P., Sidek, H., Suppiah, J., et al. (2011): Molecular analysis of 2009 pandemic influenza A(H1N1) in Malaysia associated with mild and severe infections. Malays. J. Pathol., 33, 7-12.
32. de la Rosa-Zamboni, D., Vazquez-Perez, J.A., Avila-Rios, S., et al. (2012): Molecular Characterization of the Predominant Influenza A(H1N1)pdm09 Virus in Mexico, December 2011-February 2012. PLoS One, 7, e50116.
33. Wang, W., Suguitan, A.L., Jr., Zengel, J., et al. (2012): Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage. Vaccine, 30, 872-878.
34. Kao, C.L., Chan, T.C., Tsai, C.H., et al. (2012): Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10. PLoS One, 7, e31162.
35. Chen, H., Cheung, C.L., Tai, H., et al. (2009): Oseltamivir resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg. Infect. Dis., 15, 1970-1972.
36. World Health Organization (2009): Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. Wkly. Epidemiol. Rec., 84, 453-458.
37. World Health Organization (2010): Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus, January 2010. Wkly. Epidemiol. Rec., 85, 37-39.
38. Morlighem, J.E., Aoki, S., Kishima, M., et al. (2011): Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic. PLoS One, 6, e18956.
39. Esposito, S., Molteni, C.G., Daleno, C., et al. (2010): Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy. Virol. J., 7, 202.
40. Karthick, V., Shanthi, V., Rajasekaran, R., et al. (2013): In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir. Protoplasma, 250, 197-207.